Haemonetics HAE
NYSE HAE
$108.58 +0.17 (+0.16%)
At close: Aug 20, 2026 · 10:17 AM UTC

Haemonetics (HAE) Work In Process (2011)

Haemonetics (HAE) posted quarterly Work In Process of $4.3 million for Q4 2011, down 17.21% quarter-over-quarter from $5.2 million in Q3 2011.

Haemonetics (HAE) Work In Process (2011) Analysis & Trends

Haemonetics' Work In Process history runs 1 years deep, the most recent figure standing at $4.3 million for Q4 2011.

  • In Q4 2011, Work In Process changed N/A year-over-year to $4.3 million; the TTM figure through Oct 2011 stood at $4.3 million (changed N/A YoY), while the FY2011 annual figure was $4.4 million, changed N/A from the prior year.
  • Work In Process for Q4 2011 stood at $4.3 million, down from $5.2 million in the prior quarter.
  • The five-year high for Work In Process was $5.2 million in Q3 2011, with the low at $4.3 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.70 Bn 194.09 Bn 7.27 Bn
2 Stryker 129.93 Bn 126.46 Bn 4.50 Bn
3 Medtronic 120.49 Bn 111.27 Bn 6.41 Bn
4 Boston Scientific 74.60 Bn 74.06 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.42 Bn 1.35 Bn
6 Dexcom 34.78 Bn 32.84 Bn 830.00 Mn
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn
8 Koninklijke Philips 26.44 Bn 23.12 Bn 4.55 Bn
9 Steris 23.18 Bn 22.69 Bn 684.20 Mn
10 Haemonetics 4.93 Bn 4.70 Bn 202.80 Mn

Historic Data

Download Data
DateValue
Oct 1, 2011 4.30 Mn
Jul 2, 2011 5.20 Mn
Apr 2, 2011 4.35 Mn